Published in Cell · View the paper (DOI)
Researchers argue that targeting neuraminidase, the 'N' protein, could substantially decrease infection rates and reduce disease severity for those infected with the influenza virus. The current anti-flu vaccines concentrate on hemagglutinin, leaving a big hole in immunity.
Coverage from 2 institutions